Cargando…

Development of ssDNA Aptamers for Diagnosis and Inhibition of the Highly Pathogenic Avian Influenza Virus Subtype H5N1

Avian influenza (AI) has severely affected the poultry industry worldwide and has caused the deaths of millions of birds. Highly pathogenic avian influenza virus is characterized by high mortality and the ability to transmit from birds to humans. Early diagnosis is difficult because of the variation...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sang-Heon, Choi, Jae-Woo, Kim, A-Ru, Lee, Sang-Choon, Yoon, Moon-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465229/
https://www.ncbi.nlm.nih.gov/pubmed/32731467
http://dx.doi.org/10.3390/biom10081116
_version_ 1783577542064603136
author Kim, Sang-Heon
Choi, Jae-Woo
Kim, A-Ru
Lee, Sang-Choon
Yoon, Moon-Young
author_facet Kim, Sang-Heon
Choi, Jae-Woo
Kim, A-Ru
Lee, Sang-Choon
Yoon, Moon-Young
author_sort Kim, Sang-Heon
collection PubMed
description Avian influenza (AI) has severely affected the poultry industry worldwide and has caused the deaths of millions of birds. Highly pathogenic avian influenza virus is characterized by high mortality and the ability to transmit from birds to humans. Early diagnosis is difficult because of the variation in pathogenicity and the genetic diversity between virus subtypes. Therefore, development of a sensitive and accurate diagnostic system is an urgent priority. We developed ssDNA aptamer probes to detect AI viruses. Through seven rounds of SELEX to search for a probe specific to the highly pathogenic AI virus subtype H5N1, we identified 16 binding aptamers and selected two with the highest binding frequency. These two aptamers had strong binding affinities and low detection limits. We found that they could bind more specifically to H5N1, as compared to other subtypes. Furthermore, these aptamers inhibited hemagglutination, which is caused by the virus surface protein hemagglutinin. Our results indicate that our screened aptamers are effective molecular probes for diagnosing H5N1 and can be used as therapeutic agents to inhibit viral surface proteins. Sensitive diagnosis and suppression of avian influenza will help maintain a stable and healthy livestock industry, as well as protect human health.
format Online
Article
Text
id pubmed-7465229
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74652292020-09-04 Development of ssDNA Aptamers for Diagnosis and Inhibition of the Highly Pathogenic Avian Influenza Virus Subtype H5N1 Kim, Sang-Heon Choi, Jae-Woo Kim, A-Ru Lee, Sang-Choon Yoon, Moon-Young Biomolecules Article Avian influenza (AI) has severely affected the poultry industry worldwide and has caused the deaths of millions of birds. Highly pathogenic avian influenza virus is characterized by high mortality and the ability to transmit from birds to humans. Early diagnosis is difficult because of the variation in pathogenicity and the genetic diversity between virus subtypes. Therefore, development of a sensitive and accurate diagnostic system is an urgent priority. We developed ssDNA aptamer probes to detect AI viruses. Through seven rounds of SELEX to search for a probe specific to the highly pathogenic AI virus subtype H5N1, we identified 16 binding aptamers and selected two with the highest binding frequency. These two aptamers had strong binding affinities and low detection limits. We found that they could bind more specifically to H5N1, as compared to other subtypes. Furthermore, these aptamers inhibited hemagglutination, which is caused by the virus surface protein hemagglutinin. Our results indicate that our screened aptamers are effective molecular probes for diagnosing H5N1 and can be used as therapeutic agents to inhibit viral surface proteins. Sensitive diagnosis and suppression of avian influenza will help maintain a stable and healthy livestock industry, as well as protect human health. MDPI 2020-07-28 /pmc/articles/PMC7465229/ /pubmed/32731467 http://dx.doi.org/10.3390/biom10081116 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Sang-Heon
Choi, Jae-Woo
Kim, A-Ru
Lee, Sang-Choon
Yoon, Moon-Young
Development of ssDNA Aptamers for Diagnosis and Inhibition of the Highly Pathogenic Avian Influenza Virus Subtype H5N1
title Development of ssDNA Aptamers for Diagnosis and Inhibition of the Highly Pathogenic Avian Influenza Virus Subtype H5N1
title_full Development of ssDNA Aptamers for Diagnosis and Inhibition of the Highly Pathogenic Avian Influenza Virus Subtype H5N1
title_fullStr Development of ssDNA Aptamers for Diagnosis and Inhibition of the Highly Pathogenic Avian Influenza Virus Subtype H5N1
title_full_unstemmed Development of ssDNA Aptamers for Diagnosis and Inhibition of the Highly Pathogenic Avian Influenza Virus Subtype H5N1
title_short Development of ssDNA Aptamers for Diagnosis and Inhibition of the Highly Pathogenic Avian Influenza Virus Subtype H5N1
title_sort development of ssdna aptamers for diagnosis and inhibition of the highly pathogenic avian influenza virus subtype h5n1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465229/
https://www.ncbi.nlm.nih.gov/pubmed/32731467
http://dx.doi.org/10.3390/biom10081116
work_keys_str_mv AT kimsangheon developmentofssdnaaptamersfordiagnosisandinhibitionofthehighlypathogenicavianinfluenzavirussubtypeh5n1
AT choijaewoo developmentofssdnaaptamersfordiagnosisandinhibitionofthehighlypathogenicavianinfluenzavirussubtypeh5n1
AT kimaru developmentofssdnaaptamersfordiagnosisandinhibitionofthehighlypathogenicavianinfluenzavirussubtypeh5n1
AT leesangchoon developmentofssdnaaptamersfordiagnosisandinhibitionofthehighlypathogenicavianinfluenzavirussubtypeh5n1
AT yoonmoonyoung developmentofssdnaaptamersfordiagnosisandinhibitionofthehighlypathogenicavianinfluenzavirussubtypeh5n1